1.
Ravikirti, Roy R, Pattadar C, Raj R, Agarwal N, Biswas B, et al. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. J Pharm Pharm Sci [Internet]. 2021 Jul. 15 [cited 2024 Jul. 17];24(3):343-50. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32105